タンパク質発現市場規模、シェア、動向、2031年までの世界予測

世界のタンパク質発現市場は、2026年の51億4,000万米ドルから2031年には76億5,000万米ドルに成長し、2026年から2031年までの年平均成長率（CAGR）は8.3%に達するとMarketsandMarketsでは予測しています。

世界のタンパク質発現市場は、バイオ医薬品およびバイオシミラーのパイプラインの拡大、組換えタンパク質の需要増加、細胞・遺伝子治療やmRNA製品などの先進的な治療法の成長に牽引され、予測期間中に力強い成長が見込まれています。市場予測では、発現システムの技術革新とバイオ医薬品製造活動の活発化に支えられ、2031年まで堅調な拡大が続くとされています。しかしながら、高度な発現技術の高コスト、プロセスのスケーラビリティに関する課題、専門知識の必要性、地域ごとの規制要件の違いなどが、市場全体の成長を抑制する要因となる可能性があります。

調査概要

本調査レポートは、タンパク質発現市場を、提供形態、タイプ、ワークフロー、事業規模、タンパク質の種類、用途、エンドユーザー（製品およびサービスのエンドユーザー）、地域別に分類しています。レポートの範囲は、タンパク質発現市場の成長に影響を与える主要な要因（推進要因、課題、機会、制約など）に関する詳細な情報を網羅しています。主要な業界プレーヤーの詳細な分析を行い、事業概要、製品ポートフォリオ、製品およびサービスの承認・発売、提携、パートナーシップ、事業拡大、契約、タンパク質発現市場に関連する最近の動向といった主要戦略に関する洞察を提供します。本レポートは、タンパク質発現市場のエコシステムにおける主要プレーヤーと新興スタートアップの競合分析を網羅しています。

レポート購入の主なメリット

本レポートは、市場リーダーや新規参入企業に対し、タンパク質発現市場全体およびそのサブセグメントの収益に関する最も正確な推定値を提供します。また、関係者が競争環境をより深く理解し、事業をより効果的に位置づけ、適切な市場参入戦略を策定するための洞察を得るのに役立ちます。本レポートは、関係者が市場の動向を把握し、主要な市場推進要因、阻害要因、機会、課題に関する情報を得ることを可能にするものです。

本レポートは、以下のポイントに関する洞察を提供します。

タンパク質発現市場の成長に影響を与える主要な推進要因（世界的なバイオ医薬品およびバイオシミラーのパイプラインの増加、政府およびベンチャーキャピタルによる研究開発資金の増加、発現技術における継続的なイノベーション）、阻害要因（高額な設備投資および運用コスト）、機会（新たな藻類発現システム、無細胞系や植物由来発現システムなどのプラットフォームの普及拡大、AI/MLを活用した発現最適化）、および課題（ベンチスケールからGMP製造までのスケーラビリティの課題）の分析

• 製品開発／イノベーション：タンパク質発現市場における新製品に関する詳細な洞察
• 市場開発：有望な市場に関する包括的な情報 ― 本レポートは、様々な地域におけるタンパク質発現市場を分析しています。
• 市場の多様化：タンパク質発現市場における新製品、未開拓地域、最近の動向、および投資に関する包括的な情報
• 競合評価：Thermo Fisher Scientific Inc.（米国）、Merck KGaAなどの主要企業の市場シェア、成長戦略、および製品提供に関する詳細な評価（ドイツ）、ダナハー・コーポレーション（米国）、アジレント・テクノロジー（米国）、ザルトリウスAG（ドイツ）など

Report Description

The global protein expression market is estimated to reach USD 7.65 billion by 2031, up from USD 5.14 billion in 2026, at a CAGR of 8.3% from 2026 to 2031. The global protein expression market is projected to witness strong growth over the forecast period, driven by the expanding biologics and biosimilars pipeline, increasing demand for recombinant proteins, and growth in advanced modalities such as cell and gene therapies and mRNA products. Market estimates indicate robust expansion through 2031, supported by technological advancements in expression systems and rising biologics manufacturing activities. However, high costs of advanced expression technologies, process scalability challenges, the need for specialized expertise, and varying regulatory requirements across regions are expected to restrain broader market growth.

“The product segment accounted for the largest share, by offering, in 2025.”

Based on offerings, the protein expression market is broadly segmented into products and services. In 2025, products accounted for the largest share of the protein expression market, driven by their extensive use in routine protein production workflows, including cell culture, transfection, vector preparation, protein purification, and expression optimization. Their ease of use, recurring purchase requirements, and compatibility with automated and high-throughput platforms make them essential across research and manufacturing environments. Additionally, their cost-effectiveness and ability to enable reproducible, efficient protein production continue to drive strong demand from biopharmaceutical companies, CROs, academic institutions, and research laboratories globally.

“Mammalian expression systems accounted for the largest share of the protein expression market, by type, in 2025.”

Based on type, the global protein expression market is segmented into mammalian, prokaryotic, insect, yeast, cell-free, and algal & plant-based expression systems. The mammalian expression systems segment accounted for the largest share of the protein expression market in 2025, due to its widespread use in producing complex recombinant proteins, monoclonal antibodies, and therapeutic biologics. These systems enable proper protein folding, post-translational modifications, and glycosylation patterns essential for biopharmaceutical applications. Additionally, the expanding biologics pipeline, increasing demand for high-quality therapeutic proteins, and growing commercial-scale manufacturing activities continue to strengthen the segment’s leading market position globally.

“The Asia Pacific is growing at the highest CAGR in the protein expression market from 2026 to 2031.”

The protein expression market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. During the forecast period, the Asia Pacific region is estimated to grow at the highest CAGR, driven by expanding biopharmaceutical manufacturing, rising investments in biotechnology research, and increasing demand for biologics and biosimilars. Growth is further driven by the rapid expansion of contract research and manufacturing organizations (CROs/CDMOs), improvements in healthcare and research infrastructure, and the increasing adoption of advanced protein expression technologies. Additionally, the presence of major regional and global players, including Samsung Biologics and WuXi AppTec, continues to strengthen biologics development and protein production capabilities across the region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side – 70% and Demand Side – 30%
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: CXOs and Directors – 30%, Managers – 45%, and Others – 25%
• By Region: North America – 40%, Europe – 25%, Asia Pacific – 20%, Latin America – 10%, and the Middle East – 5%

List of Companies Profiled in the Report

• Thermo Fisher Scientific Inc.
• Merck Kgaa
• Danaher Corporation
• Agilent Technologies, Inc
• Sartorius Ag
• Genscript
• Takara Bio Inc.
• Bio-Rad Laboratories, Inc
• QIAGEN
• Charles River Laboratories
• Corning Incorporated
• Lonza
• Fujifilm Corporation
• Syngene International
• Lgc Limited
• Eurofins Scientific
• Ajinomoto Co., Inc

Research Coverage

This research report categorizes the protein expression market by offering, type, workflow, scale of operation, protein modality, application, by end user (product & service end users), and by region. The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the protein expression market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product and service approvals and launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the protein expression market. This report covers competitive analysis of top players and upcoming startups in the protein expression market ecosystem.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing the closest approximations of revenue for the overall protein expression market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business more effectively and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

• Analysis of key drivers (increasing global biologics and biosimilar pipeline, rising government and venture capital R&D funding, continuous innovation in expression technologies), restraints (high capital and operational costs), opportunities (emerging algal expression systems and broader adoption of platforms such as cell-free, plant-based expression systems, AI/ML-driven expression optimization) and challenges (scalability Challenge from bench to GMP manufacturing) influencing the growth of protein expression market
• Product Development/Innovation: Detailed insights on newly launched products of the protein expression market
• Market Development: Comprehensive information about lucrative markets – the report analyses the protein expression market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the protein expression market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Agilent Technologies, Inc. (US), Sartorius AG (Germany), among others

Table of Contents

1 INTRODUCTION 66
1.1 STUDY OBJECTIVES 66
1.2 MARKET DEFINITION 66
1.3 MARKET SCOPE 67
1.3.1 MARKETS COVERED 67
1.3.2 INCLUSIONS & EXCLUSIONS 68
1.3.3 YEARS CONSIDERED 69
1.3.4 CURRENCY CONSIDERED 69
1.4 STAKEHOLDERS 70
2 EXECUTIVE SUMMARY 71
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 71
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 73
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 74
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 75
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 76
3 PREMIUM INSIGHTS 77
3.1 PROTEIN EXPRESSION MARKET OVERVIEW 77
3.2 PROTEIN EXPRESSION MARKET, BY OFFERING & REGION 78
3.3 PROTEIN EXPRESSION MARKET: GEOGRAPHIC SNAPSHOT 79
4 MARKET OVERVIEW 80
4.1 INTRODUCTION 80
4.2 MARKET DYNAMICS 80
4.2.1 DRIVERS 81
4.2.1.1 Increasing global biologics and biosimilars pipeline 81
4.2.1.2 Rising government and venture capital R&D funding 82
4.2.1.3 Continuous innovation in expression technologies 82
4.2.2 RESTRAINTS 82
4.2.2.1 High capital and operational costs 82
4.2.3 OPPORTUNITY 83
4.2.3.1 Emerging algal expression systems and rising adoption of advanced platforms 83
4.2.3.2 Al/ML-driven expression optimization 83
4.2.4 CHALLENGES 84
4.2.4.1 Scalability challenges from bench to GMP manufacturing 84
4.3 UNMET NEEDS AND WHITE SPACES 84
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 85
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 86
5 INDUSTRY TRENDS 87
5.1 PORTER’S FIVE FORCES ANALYSIS 87
5.1.1 THREAT OF NEW ENTRANTS 88
5.1.2 THREAT OF SUBSTITUTES 88
5.1.3 BARGAINING POWER OF BUYERS 88
5.1.4 BARGAINING POWER OF SUPPLIERS 88
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.2 MACROECONOMIC OUTLOOK 89
5.2.1 INTRODUCTION 89
5.2.2 GDP TRENDS AND FORECAST 89
5.2.3 TRENDS IN GLOBAL PROTEIN EXPRESSION MARKET 90
5.3 VALUE CHAIN ANALYSIS 90
5.3.1 PROTEIN EXPRESSION PRODUCTS 91
5.3.2 PROTEIN EXPRESSION SERVICES 92
5.4 ECOSYSTEM ANALYSIS 93
5.5 PRICING ANALYSIS 94
5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025 94
5.5.2 INDICATIVE SELLING PRICE, BY REGION, 2025 96
5.6 TRADE ANALYSIS 97
5.6.1 IMPORT SCENARIO FOR HS CODE 902781 97
5.6.2 EXPORT SCENARIO FOR HS CODE 902781 98
5.7 KEY CONFERENCES & EVENTS 100
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 101
5.9 INVESTMENT/FUNDING SCENARIO 101
5.10 IMPACT OF US TARIFFS—PROTEIN EXPRESSION MARKET 102
5.10.1 INTRODUCTION 102
5.10.2 KEY TARIFF RATES 103
5.10.3 PRICE IMPACT ANALYSIS 104
5.10.4 IMPACT ON COUNTRIES/REGIONS 104
5.10.4.1 North America 104
5.10.4.2 Europe 105
5.10.4.3 Asia Pacific 105
5.10.5 IMPACT ON END-USE INDUSTRIES 106
5.10.5.1 Pharmaceutical and biotechnology companies 106
5.10.5.2 Academic & Research Institutes 106
5.10.5.3 CROs & CDMOs 106
5.11 BIOMANUFACTURING CAPACITY 107
5.12 NIH FUNDING FOR PROTEIN-RELATED RESEARCH 107
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 108
6.1 KEY TECHNOLOGIES 108
6.1.1 RECOMBINANT DNA TECHNOLOGY 108
6.1.2 TRANSFECTION TECHNOLOGIES 108
6.2 ADJACENT TECHNOLOGIES 109
6.2.1 EXTRACTION TECHNOLOGIES 109
6.3 COMPLEMENTARY TECHNOLOGIES 109
6.3.1 HIGH-THROUGHPUT TECHNOLOGIES 109
6.3.2 COMPUTATION PROTEIN DESIGNING 109
6.4 TECHNOLOGY/PRODUCT ROADMAP 110
6.5 PATENT ANALYSIS 111
6.5.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015–2025 111
6.6 FUTURE APPLICATIONS 113
6.7 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET 113
6.7.1 TOP USE CASES AND MARKET POTENTIAL 114
6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET 115
6.7.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 115
6.7.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET 116
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 117
7.1 REGIONAL REGULATIONS AND COMPLIANCE 117
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117
7.1.2 REGULATORY FRAMEWORK 120
7.1.3 INDUSTRY STANDARDS 122
7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 123
7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 123
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 125
8.1 DECISION-MAKING PROCESS 125
8.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA 126
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 126
8.2.2 KEY BUYING CRITERIA, BY END USER 126
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 128
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 128
8.5 MARKET PROFITABILITY 129

9 PROTEIN EXPRESSION MARKET, BY OFFERING 130
9.1 INTRODUCTION 131
9.2 PRODUCTS 131
9.2.1 REAGENTS 135
9.2.1.1 Culture media & supplements 139
9.2.1.1.1 Optimized and GMP-ready media formulations to support scalable protein expression 139
9.2.1.2 Expression vectors & plasmids 142
9.2.1.2.1 Growing production of complex proteins to propel market 142
9.2.1.3 Transduction & transfection reagents 145
9.2.1.3.1 High-efficiency gene delivery reagents to improve transient and stable protein expression 145
9.2.1.4 Competent cells 148
9.2.1.4.1 Increasing demand for therapeutic proteins to expedite growth 148
9.2.1.5 Other reagents 151
9.2.2 INSTRUMENTS 154
9.2.2.1 Bioreactors & fermenters 157
9.2.2.1.1 Rising biologics research to drive adoption of advanced bioreactor systems 157
9.2.2.2 Chromatography systems 160
9.2.2.2.1 Expanding recombinant protein and antibody research accelerates demand for automated lab-scale systems 160
9.2.2.3 Analytical instruments 164
9.2.2.3.1 Rising need for rapid protein quality assessment and characterization drives demand for analytical instruments 164
9.2.2.4 Liquid handling & automated systems 167
9.2.2.4.1 High-throughput expression screening and workflow miniaturization to propel adoption 167
9.2.2.5 Filtration systems 170
9.2.2.5.1 Growing need for rapid and scalable post-expression processing driving global adoption 170
9.2.2.6 Other instruments 173
9.2.3 CONSUMABLES 176
9.2.3.1 Chromatography & purification consumables 180
9.2.3.1.1 Increasing need for high-purity recombinant proteins is accelerating adoption 180
9.2.3.2 Filtration & separation consumables 183
9.2.3.2.1 Rising demand for rapid, small-scale protein processing workflows is driving growth 183
9.2.3.3 Other consumables 186
9.2.4 KITS 189
9.2.4.1 Expression kits 192
9.2.4.1.1 Standardized, high-throughput expression kits accelerate recombinant protein discovery and workflow reproducibility 192
9.2.4.2 Cloning & mutagenesis kits 195
9.2.4.2.1 Rapid construct engineering kits to accelerate expression-ready clone development 195
9.2.4.3 Other kits 198
9.2.5 SOFTWARE 201
9.2.5.1 AI-enabled design, codon optimization, and workflow informatics drive software adoption 201
9.3 SERVICES 204
9.3.1 CUSTOM PROTEIN EXPRESSION SERVICES 208
9.3.1.1 Rising demand for specialized recombinant protein production supports expansion of custom services 208
9.3.2 GENE SYNTHESIS & CLONING SERVICES 211
9.3.2.1 Reduced workload, improved accuracy, optimized workflows to drive demand 211
9.3.3 CELL LINE DEVELOPMENT (CLD) SERVICES 214
9.3.3.1 Outsourcing of high-yield mammalian cell line development drives growth 214
9.3.4 PROCESS DEVELOPMENT & SCALE-UP SERVICES 217
9.3.4.1 Rising need to translate expression hits into scalable preclinical protein production supports demand growth 217
10 PROTEIN EXPRESSION MARKET, BY TYPE 220
10.1 INTRODUCTION 221
10.2 MAMMALIAN CELL EXPRESSION SYSTEMS 221
10.2.1 CHINESE HAMSTER OVARY (CHO) CELL SYSTEMS 225
10.2.1.1 High viability, rapid growth, and improved expression levels to support growth 225
10.2.2 HUMAN EMBRYONIC KIDNEY (HEK 293) CELL SYSTEMS 229
10.2.2.1 Wide usage in transient transfection studies to augment growth 229
10.2.3 OTHER MAMMALIAN CELL EXPRESSION SYSTEMS 232
10.3 PROKARYOTIC EXPRESSION SYSTEMS 235
10.3.1 ESCHERICHIA COLI SYSTEMS 239
10.3.1.1 Increasing use of E. coli systems for commercial protein production to support market 239
10.3.2 BACILLUS SYSTEMS 242
10.3.2.1 Efficient secretion capabilities drive growing adoption 242
10.3.3 OTHER PROKARYOTIC EXPRESSION SYSTEMS 246
10.4 INSECT CELL EXPRESSION SYSTEMS 249
10.4.1 BACULOVIRUS SYSTEMS 252
10.4.1.1 High protein yield and expression levels of intracellular proteins through the baculovirus expression system to support growth 252
10.4.2 OTHER INSECT CELL SYSTEMS 256
10.5 YEAST EXPRESSION SYSTEMS 259
10.5.1 PICHIA SYSTEMS 263
10.5.1.1 High scalability and efficient protein production to support growth 263
10.5.2 SACCHAROMYCES SYSTEMS 266
10.5.2.1 Efficient secretory pathways and scalable recombinant protein production to support market growth 266
10.5.3 OTHER YEAST EXPRESSION SYSTEMS 269
10.6 CELL-FREE EXPRESSION SYSTEMS 272
10.6.1 E. COLI LYSATE-BASED SYSTEMS 276
10.6.1.1 Rapid and flexible platforms for protein synthesis to drive adoption 276
10.6.2 OTHER CELL-FREE EXPRESSION SYSTEMS 279
10.7 ALGAL & PLANT-BASED EXPRESSION SYSTEMS 282
10.7.1 GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT 282
11 PROTEIN EXPRESSION MARKET, BY WORKFLOW 286
11.1 INTRODUCTION 287
11.2 CLONING & TRANSFECTION 287
11.2.1 CONTINUOUS REPLENISHMENT OF CONSUMABLES AND REAGENTS TO SUPPORT THE MARKET 287
11.3 TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION (PTM) 291
11.3.1 GROWING NEED FOR FUNCTIONAL AND STABLE PROTEINS TO DRIVE MARKET 291
11.4 EXTRACTION, PURIFICATION, AND CHARACTERIZATION 294
11.4.1 NEED TO ADHERE TO REQUIRED STANDARDS FOR SUITABLE APPLICATIONS TO DRIVE MARKET 294
12 PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION 298
12.1 INTRODUCTION 299
12.2 DISCOVERY & RESEARCH SCALE 299
12.2.1 EXPANDING BIOLOGICS PIPELINE AND FOCUS ON COMPUTATIONALLY DESIGNED PROTEINS TO AID GROWTH 299
12.3 PRECLINICAL & CHARACTERIZATION SCALE 303
12.3.1 SIGNIFICANT NUMBER OF BIOLOGIC CANDIDATES ENTERING PRE-CLINICAL DEVELOPMENT TO BOOST THE MARKET 303
12.4 PROCESS DEVELOPMENT & PILOT SCALE 306
12.4.1 INCREASING OUTSOURCING OF EXPRESSION AT PROCESS DEVELOPMENT SCALE TO SUPPORT GROWTH 306
13 PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY 310
13.1 INTRODUCTION 311
13.2 MONOCLONAL ANTIBODIES & DERIVATIVES 311
13.2.1 EXPANDING ANTIBODY DISCOVERY, BISPECIFIC DEVELOPMENT, AND MAMMALIAN EXPRESSION OPTIMIZATION DRIVE DEMAND 311
13.3 RECOMBINANT THERAPEUTIC PROTEINS 315
13.3.1 INCREASING DEVELOPMENT OF RECOMBINANT BIOLOGICS AND ENGINEERED THERAPEUTIC PROTEINS IS DRIVING DEMAND 315

13.4 VACCINES 318
13.4.1 RISING DEMAND FOR RECOMBINANT ANTIGENS AND NEXT-GENERATION VACCINE PLATFORMS DRIVES PROTEIN EXPRESSION ADOPTION IN VACCINE RESEARCH 318
13.5 ENZYMES & CATALYTIC PROTEINS 321
13.5.1 EXPANDING ENZYME ENGINEERING AND BIOCATALYSIS APPLICATIONS ARE ACCELERATING DEMAND 321
13.6 OTHER PROTEINS 324
14 PROTEIN EXPRESSION MARKET, BY APPLICATION 328
14.1 INTRODUCTION 329
14.2 THERAPEUTIC APPLICATIONS 329
14.2.1 RISING DEMAND FOR BIOLOGICS THERAPIES TO FACILITATE GROWTH 329
14.3 RESEARCH APPLICATIONS 333
14.3.1 GROWING INTEREST IN PROTEOMICS, GENOMICS, AND DRUG DISCOVERY TO BOOST MARKET 333
14.4 INDUSTRIAL APPLICATIONS 337
14.4.1 INCREASING USE OF PROTEINS IN COSMETICS, TEXTILES, AND INDUSTRIAL ENZYMES TO PROMOTE GROWTH 337
14.5 DIAGNOSTIC APPLICATIONS 341
14.5.1 RECOMBINANT PROTEINS AND ASSAY-READY REAGENTS TO STRENGTHEN DIAGNOSTIC DEVELOPMENT 341
15 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER 345
15.1 INTRODUCTION 346
15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 346
15.2.1 RISING INVESTMENT IN BIOLOGICS AND INCREASING APPROVALS FOR BIOLOGICS TO SUPPORT GROWTH 346
15.3 CROS & CDMOS 350
15.3.1 INCREASE IN OUTSOURCING AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET 350
15.4 ACADEMIC & RESEARCH INSTITUTES 353
15.4.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET 353
15.5 OTHER END USERS 357
16 PROTEIN EXPRESSION SERVICES MARKET, BY END USER 361
16.1 INTRODUCTION 362
16.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 362
16.2.1 INCREASING SHIFT TOWARD DRUG DEVELOPMENT OUTSOURCING TO FAVOR GROWTH 362
16.3 ACADEMIC & RESEARCH INSTITUTES 366
16.3.1 RISING PARTNERSHIPS BETWEEN ACADEMIA AND CONTRACT RESEARCH ORGANIZATIONS TO AID GROWTH 366
16.4 OTHER END USERS 369
17 PROTEIN EXPRESSION MARKET, BY REGION 373
17.1 INTRODUCTION 374
17.2 NORTH AMERICA 374
17.2.1 US 385
17.2.1.1 Growing focus on developing new therapeutics and protein-based drugs to drive market 385
17.2.2 CANADA 394
17.2.2.1 Increasing incidence of cancer and prevalence of public-private partnerships to sustain growth 394
17.3 EUROPE 403
17.3.1 GERMANY 411
17.3.1.1 Increasing proteomics-based research and healthcare investments to promote growth 411
17.3.2 UK 420
17.3.2.1 Growing development of immunotherapies, vaccines, and proteomics to fuel market 420
17.3.3 FRANCE 428
17.3.3.1 Rise in funding for proteomics and genomics to spur growth 428
17.3.4 ITALY 437
17.3.4.1 Growing life science research supported by universities and research institutions to boost market 437
17.3.5 SPAIN 445
17.3.5.1 Growing expansion of biotech companies and increasing R&D expenditure to drive market 445
17.3.6 NETHERLANDS 452
17.3.6.1 Presence of advanced infrastructure to fuel market 452
17.3.7 REST OF EUROPE 460
17.4 ASIA PACIFIC 470
17.4.1 CHINA 480
17.4.1.1 Rising biologics development driving market growth 480
17.4.2 JAPAN 488
17.4.2.1 Growing government initiatives and expansion of biopharma companies to boost market 488
17.4.3 INDIA 496
17.4.3.1 Rising collaborations between private sector and academia to facilitate growth 496
17.4.4 AUSTRALIA 504
17.4.4.1 Strong regulatory framework, clinical innovation, and global partnerships drive market growth 504
17.4.5 SOUTH KOREA 512
17.4.5.1 Increasing research & development of novel therapies to facilitate growth 512
17.4.6 REST OF ASIA PACIFIC 520

17.5 LATIN AMERICA 529
17.5.1 BRAZIL 537
17.5.1.1 Growing industrial investments to propel market 537
17.5.2 MEXICO 545
17.5.2.1 Increasing government support for biopharmaceutical production to drive market 545
17.5.3 ARGENTINA 552
17.5.3.1 Rise in biotechnology and pharmaceutical research & development to augment growth 552
17.5.4 REST OF LATIN AMERICA 560
17.6 MIDDLE EAST 568
17.6.1 GCC COUNTRIES 576
17.6.1.1 Saudi Arabia 584
17.6.1.1.1 Rising demand for biologics and increasing healthcare investments to support market growth 584
17.6.1.2 United Arab Emirates 592
17.6.1.2.1 Developing biopharma sector to drive market 592
17.6.1.3 Rest of GCC countries 600
17.6.2 REST OF MIDDLE EAST 608
17.7 AFRICA 617
18 COMPETITIVE LANDSCAPE 625
18.1 OVERVIEW 625
18.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 625
18.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PROTEIN EXPRESSION MARKET 626
18.3 REVENUE ANALYSIS 627
18.4 MARKET SHARE ANALYSIS 628
18.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 630
18.5.1 STARS 630
18.5.2 EMERGING LEADERS 630
18.5.3 PERVASIVE PLAYERS 631
18.5.4 PARTICIPANTS 631
18.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 632
18.5.5.1 Company footprint 632
18.5.5.2 Region footprint 633
18.5.5.3 Offering footprint 634
18.5.5.4 Type footprint 635
18.5.5.5 Application footprint 637
18.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 638
18.6.1 PROGRESSIVE COMPANIES 638
18.6.2 RESPONSIVE COMPANIES 638
18.6.3 DYNAMIC COMPANIES 638
18.6.4 STARTING BLOCKS 638
18.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 640
18.6.5.1 Detailed list of key startups/SMEs 640
18.6.5.2 Competitive benchmarking of key startups/SMEs 641
18.7 COMPANY VALUATION AND FINANCIAL METRICS 642
18.7.1 COMPANY VALUATION 642
18.7.2 FINANCIAL METRICS 642
18.8 BRAND/PRODUCT COMPARISON 643
18.9 COMPETITIVE SCENARIO 644
18.9.1 PRODUCT & SERVICE LAUNCHES 644
18.9.2 DEALS 645
18.9.3 EXPANSIONS 646
19 COMPANY PROFILES 647
19.1 MAJOR PLAYERS 647
19.1.1 THERMO FISHER SCIENTIFIC INC. 647
19.1.1.1 Business overview 647
19.1.1.2 Products & services offered 648
19.1.1.3 Recent developments 652
19.1.1.3.1 Product & service launches 652
19.1.1.3.2 Deals 653
19.1.1.3.3 Expansions 653
19.1.1.4 MnM view 654
19.1.1.4.1 Key strengths 654
19.1.1.4.2 Strategic choices 654
19.1.1.4.3 Weaknesses and competitive threats 654
19.1.2 MERCK KGAA 655
19.1.2.1 Business overview 655
19.1.2.2 Products & services offered 656
19.1.2.3 Recent developments 659
19.1.2.3.1 Deals 659
19.1.2.3.2 Expansions 659
19.1.2.4 MnM view 661
19.1.2.4.1 Key strengths 661
19.1.2.4.2 Strategic choices 661
19.1.2.4.3 Weaknesses and competitive threats 661
19.1.3 DANAHER CORPORATION 662
19.1.3.1 Business overview 662
19.1.3.2 Products & services offered 663
19.1.3.3 Recent developments 665
19.1.3.3.1 Product launches 665
19.1.3.3.2 Deals 666
19.1.3.3.3 Expansions 666
19.1.3.4 MnM view 667
19.1.3.4.1 Key strengths 667
19.1.3.4.2 Strategic choices 667
19.1.3.4.3 Weaknesses and competitive threats 667
19.1.4 AGILENT TECHNOLOGIES, INC. 668
19.1.4.1 Business overview 668
19.1.4.2 Products & services offered 669
19.1.4.3 Recent developments 672
19.1.4.3.1 Product launches 672
19.1.4.3.2 Deals 672
19.1.4.4 MnM view 672
19.1.4.4.1 Key strengths 672
19.1.4.4.2 Strategic choices 672
19.1.4.4.3 Weaknesses and competitive threats 673
19.1.5 SARTORIUS AG 674
19.1.5.1 Business overview 674
19.1.5.2 Products & services offered 675
19.1.5.3 Recent developments 676
19.1.5.3.1 Deals 676
19.1.5.3.2 Expansions 676
19.1.5.4 MnM view 677
19.1.5.4.1 Key strength 677
19.1.5.4.2 Strategic choices 677
19.1.5.4.3 Weaknesses and competitive threats 677
19.1.6 GENSCRIPT 678
19.1.6.1 Business overview 678
19.1.6.2 Products & services offered 679
19.1.6.3 Recent developments 680
19.1.6.3.1 Product/Service launches 680
19.1.7 TAKARA BIO INC. 681
19.1.7.1 Business overview 681
19.1.7.2 Products & services offered 682
19.1.7.3 Recent developments 684
19.1.7.3.1 Expansions 684
19.1.8 BIO-RAD LABORATORIES, INC. 685
19.1.8.1 Business overview 685
19.1.8.2 Products & services offered 686
19.1.8.3 Recent developments 688
19.1.8.3.1 Product launches 688
19.1.8.3.2 Deals 688

19.1.9 QIAGEN 689
19.1.9.1 Business overview 689
19.1.9.2 Products & services offered 690
19.1.9.3 Recent developments 691
19.1.9.3.1 Product launches 691
19.1.9.3.2 Deals 691
19.1.10 CHARLES RIVER LABORATORIES 692
19.1.10.1 Business overview 692
19.1.10.2 Products & services offered 693
19.1.10.3 Recent developments 694
19.1.10.3.1 Product/Service launches 694
19.1.11 CORNING INCORPORATED 695
19.1.11.1 Business overview 695
19.1.11.2 Products & services offered 696
19.1.11.3 Recent developments 698
19.1.11.3.1 Product launches 698
19.1.12 LONZA 699
19.1.12.1 Business overview 699
19.1.12.2 Products & services offered 700
19.1.12.3 Recent developments 702
19.1.12.3.1 Product launches 702
19.1.12.3.2 Deals 702
19.1.13 FUJIFILM HOLDINGS CORPORATION 703
19.1.13.1 Business overview 703
19.1.13.2 Products & services offered 704
19.1.13.3 Recent developments 706
19.1.13.3.1 Product launches 706
19.1.13.3.2 Expansions 706
19.1.14 SYNGENE INTERNATIONAL LIMITED 707
19.1.14.1 Business overview 707
19.1.14.2 Products & services offered 708
19.1.14.3 Recent developments 708
19.1.14.3.1 Product launches 708
19.1.15 LGC LIMITED 709
19.1.15.1 Business overview 709
19.1.15.2 Products & services offered 710
19.1.16 EUROFINS SCIENTIFIC 712
19.1.16.1 Business overview 712
19.1.16.2 Products & services offered 713
19.1.16.3 Recent developments 714
19.1.16.3.1 Expansions 714

19.1.17 AJINOMOTO CO., INC. 715
19.1.17.1 Business overview 715
19.1.17.2 Products & services offered 716
19.1.17.3 Recent developments 717
19.1.17.3.1 Deals 717
19.2 OTHER PLAYERS 718
19.2.1 PROMEGA CORPORATION 718
19.2.2 SINO BIOLOGICAL, INC. 719
19.2.3 RAYBIOTECH, INC. 720
19.2.4 BIONEER CORPORATION 721
19.2.5 ORIGENE TECHNOLOGIES, INC. 722
19.2.6 NEW ENGLAND BIOLABS 723
19.2.7 ACCURUS BIOSCIENCES 724
19.2.8 ARAGEN LIFE SCIENCES LTD. 725
19.2.9 OXFORD EXPRESSION TECHNOLOGIES LTD 726
19.2.10 PROTEOGENIX INC. 727
19.2.11 ABEOMICS 728
20 RESEARCH METHODOLOGY 729
20.1 RESEARCH DATA 729
20.1.1 SECONDARY DATA 730
20.1.2 PRIMARY DATA 730
20.2 MARKET ESTIMATION METHODOLOGY 732
20.2.1 MARKET SIZE ESTIMATION 732
20.2.2 INSIGHTS OF PRIMARY EXPERTS 734
20.2.3 TOP-DOWN APPROACH 735
20.3 MARKET GROWTH RATE PROJECTIONS 736
20.4 MARKET BREAKDOWN AND DATA TRIANGULATION 738
20.5 RESEARCH ASSUMPTIONS 739
20.6 RESEARCH LIMITATIONS 739
20.7 RISK ANALYSIS 740
21 APPENDIX 741
21.1 DISCUSSION GUIDE 741
21.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 745
21.3 CUSTOMIZATION OPTIONS 747
21.4 RELATED REPORTS 747
21.5 AUTHOR DETAILS 748

LIST OF TABLES

TABLE 1 PROTEIN EXPRESSION MARKET: IMPACT ANALYSIS 81
TABLE 2 PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS 88
TABLE 3 PROTEIN EXPRESSION MARKET: ROLE IN ECOSYSTEM 94
TABLE 4 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER, 2023-2025 (USD) 95
TABLE 5 INDICATIVE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY REGION,
2025 (USD) 96
TABLE 6 IMPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781),
2022–2023 (USD THOUSAND) 97
TABLE 7 IMPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781),
2022–2025, (UNIT/TONS) 98
TABLE 8 EXPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781),
2022–2025, (USD THOUSAND) 98
TABLE 9 EXPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781),
2022–2025, (UNIT/TONS) 99
TABLE 10 PROTEIN EXPRESSION MARKET: KEY CONFERENCES & EVENTS, 2026–2027 100
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 103
TABLE 12 INDICATIVE LIST OF PATENTS IN PROTEIN EXPRESSION MARKET, 2024 112
TABLE 13 CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET 115
TABLE 14 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET 116
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119
TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120
TABLE 19 COUNTRY-WISE REGULATORY SCENARIO FOR PROTEIN EXPRESSION PRODUCT & SERVICE PROVIDERS 121
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 126
TABLE 21 KEY BUYING CRITERIA, BY END USER 127
TABLE 22 PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 131
TABLE 23 PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132
TABLE 24 PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION,
2024–2031 (USD MILLION) 132
TABLE 25 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 26 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 133
TABLE 27 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 133
TABLE 28 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 134
TABLE 29 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION,
2024–2031 (USD MILLION) 134
TABLE 30 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 31 PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135
TABLE 32 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 136
TABLE 33 NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 34 EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 137
TABLE 35 ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 137
TABLE 36 LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 138
TABLE 37 MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 138
TABLE 38 GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 138
TABLE 39 CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 139
TABLE 40 NORTH AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 41 EUROPE: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 140
TABLE 42 ASIA PACIFIC: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 140
TABLE 43 LATIN AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 141
TABLE 44 MIDDLE EAST: CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 141
TABLE 45 GCC COUNTRIES: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 46 EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION,
2024–2031 (USD MILLION) 142
TABLE 47 NORTH AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 48 EUROPE: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 143
TABLE 49 ASIA PACIFIC: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 144
TABLE 50 LATIN AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 51 MIDDLE EAST: EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION,
2024–2031 (USD MILLION) 144
TABLE 52 GCC COUNTRIES: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 53 TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 145
TABLE 54 NORTH AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 55 EUROPE: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 56 ASIA PACIFIC: TRANSDUCTION & TRANSFECTION REAGENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 57 LATIN AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 58 MIDDLE EAST: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 147
TABLE 59 GCC COUNTRIES: TRANSDUCTION & TRANSFECTION REAGENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 60 COMPETENT CELLS MARKET, BY REGION, 2024–2031 (USD MILLION) 148
TABLE 61 NORTH AMERICA: COMPETENT CELLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 149
TABLE 62 EUROPE: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 63 ASIA PACIFIC: COMPETENT CELLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 149
TABLE 64 LATIN AMERICA: COMPETENT CELLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 150
TABLE 65 MIDDLE EAST: COMPETENT CELLS MARKET, BY REGION,
2024–2031 (USD MILLION) 150
TABLE 66 GCC COUNTRIES: COMPETENT CELLS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 150
TABLE 67 OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 151
TABLE 68 NORTH AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 69 EUROPE: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 152
TABLE 70 ASIA PACIFIC: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 71 LATIN AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 72 MIDDLE EAST: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 153
TABLE 73 GCC COUNTRIES: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 74 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 154
TABLE 75 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 154
TABLE 76 NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 77 EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 78 ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 79 LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 80 MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 156
TABLE 81 GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 82 PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024–2031 (USD MILLION) 157
TABLE 83 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 84 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 85 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 86 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 87 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024–2031 (USD MILLION) 159
TABLE 88 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 89 CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 161
TABLE 90 NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 161
TABLE 91 EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 162
TABLE 92 ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 162
TABLE 93 LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 163
TABLE 94 MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 163
TABLE 95 GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 163
TABLE 96 ANALYTICAL INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 164
TABLE 97 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 164
TABLE 98 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 165
TABLE 99 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 165
TABLE 100 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 166
TABLE 101 MIDDLE EAST: ANALYTICAL INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 166
TABLE 102 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 166
TABLE 103 LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 167
TABLE 104 NORTH AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 105 EUROPE: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 106 ASIA PACIFIC: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 107 LATIN AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 108 MIDDLE EAST: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 169
TABLE 109 GCC COUNTRIES: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 110 FILTRATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 170
TABLE 111 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 171
TABLE 112 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 171
TABLE 113 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 172
TABLE 114 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 172
TABLE 115 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 172
TABLE 116 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 173
TABLE 117 OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 173
TABLE 118 NORTH AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 119 EUROPE: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 120 ASIA PACIFIC: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 121 LATIN AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 122 MIDDLE EAST: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 175
TABLE 123 GCC COUNTRIES: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 124 PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 176
TABLE 125 PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 177
TABLE 126 NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 127 EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 178
TABLE 128 ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 129 LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 130 MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 179
TABLE 131 GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 132 CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 180
TABLE 133 NORTH AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 134 EUROPE: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 135 ASIA PACIFIC: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 136 LATIN AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 137 MIDDLE EAST: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET,
BY REGION, 2024–2031 (USD MILLION) 182
TABLE 138 GCC COUNTRIES: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 139 FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 183
TABLE 140 NORTH AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 141 EUROPE: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 142 ASIA PACIFIC: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 143 LATIN AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 144 MIDDLE EAST: FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 185
TABLE 145 GCC COUNTRIES: FILTRATION & SEPARATION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 146 OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION,
2024–2031 (USD MILLION) 186
TABLE 147 NORTH AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 148 EUROPE: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 149 ASIA PACIFIC: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 150 LATIN AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 151 MIDDLE EAST: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET,
BY REGION, 2024–2031 (USD MILLION) 188
TABLE 152 GCC COUNTRIES: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 153 PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 154 PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 189
TABLE 155 NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 190
TABLE 156 EUROPE: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 190
TABLE 157 ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 191
TABLE 158 LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 191
TABLE 159 MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY REGION,
2024–2031 (USD MILLION) 191
TABLE 160 GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 192
TABLE 161 EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 192
TABLE 162 NORTH AMERICA: EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 193
TABLE 163 EUROPE: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 164 ASIA PACIFIC: EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 193
TABLE 165 LATIN AMERICA: EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 194
TABLE 166 MIDDLE EAST: EXPRESSION KITS MARKET, BY REGION,
2024–2031 (USD MILLION) 194
TABLE 167 GCC COUNTRIES: EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 194
TABLE 168 CLONING & MUTAGENESIS KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 195
TABLE 169 NORTH AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 195
TABLE 170 EUROPE: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 196
TABLE 171 ASIA PACIFIC: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 196
TABLE 172 LATIN AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 197
TABLE 173 MIDDLE EAST: CLONING & MUTAGENESIS KITS MARKET, BY REGION,
2024–2031 (USD MILLION) 197
TABLE 174 GCC COUNTRIES: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 197
TABLE 175 OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION,
2024–2031 (USD MILLION) 198
TABLE 176 NORTH AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198
TABLE 177 EUROPE: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 199
TABLE 178 ASIA PACIFIC: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 199
TABLE 179 LATIN AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 180 MIDDLE EAST: OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION,
2024–2031 (USD MILLION) 200
TABLE 181 GCC COUNTRIES: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 182 PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION,
2024–2031 (USD MILLION) 201
TABLE 183 NORTH AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201
TABLE 184 EUROPE: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 202
TABLE 185 ASIA PACIFIC: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 202
TABLE 186 LATIN AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 203
TABLE 187 MIDDLE EAST: PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION,
2024–2031 (USD MILLION) 203
TABLE 188 GCC COUNTRIES: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203
TABLE 189 PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 190 PROTEIN EXPRESSION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 205
TABLE 191 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 205
TABLE 192 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 206
TABLE 193 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 206
TABLE 194 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 207
TABLE 195 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 207
TABLE 196 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 207
TABLE 197 CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 208
TABLE 198 NORTH AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 208
TABLE 199 EUROPE: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 200 ASIA PACIFIC: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 201 LATIN AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210
TABLE 202 MIDDLE EAST: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 210
TABLE 203 GCC COUNTRIES: CUSTOM PROTEIN EXPRESSION SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 210
TABLE 204 GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 211
TABLE 205 NORTH AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211
TABLE 206 EUROPE: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 212
TABLE 207 ASIA PACIFIC: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 208 LATIN AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 213
TABLE 209 MIDDLE EAST: GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 213
TABLE 210 GCC COUNTRIES: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 213
TABLE 211 CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 214
TABLE 212 NORTH AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214
TABLE 213 EUROPE: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 215
TABLE 214 ASIA PACIFIC: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 215
TABLE 215 LATIN AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 216 MIDDLE EAST: CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 216
TABLE 217 GCC COUNTRIES: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 218 PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 217
TABLE 219 NORTH AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 217
TABLE 220 EUROPE: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 221 ASIA PACIFIC: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 222 LATIN AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 219
TABLE 223 MIDDLE EAST: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET,
BY REGION, 2024–2031 (USD MILLION) 219
TABLE 224 GCC COUNTRIES: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 219
TABLE 225 PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 226 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 227 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 222
TABLE 228 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 229 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 230 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 224
TABLE 231 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 224
TABLE 232 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 224
TABLE 233 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 225
TABLE 234 PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION,
2024–2031 (USD MILLION) 226
TABLE 235 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 226
TABLE 236 EUROPE: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 227
TABLE 237 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 227
TABLE 238 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 228
TABLE 239 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 228
TABLE 240 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 228
TABLE 241 PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION,
2024–2031 (USD MILLION) 229
TABLE 242 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 230
TABLE 243 EUROPE: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 230
TABLE 244 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 231
TABLE 245 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 231
TABLE 246 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 231
TABLE 247 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 232
TABLE 248 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 232
TABLE 249 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 233
TABLE 250 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 233
TABLE 251 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 234
TABLE 252 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 234
TABLE 253 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 234
TABLE 254 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 235
TABLE 255 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 256 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 236
TABLE 257 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 236
TABLE 258 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 237
TABLE 259 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 237
TABLE 260 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 238
TABLE 261 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 238
TABLE 262 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 238
TABLE 263 PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION,
2024–2031 (USD MILLION) 239
TABLE 264 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 240
TABLE 265 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 240
TABLE 266 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 241
TABLE 267 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 241
TABLE 268 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 241
TABLE 269 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 242
TABLE 270 PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY REGION,
2024–2031 (USD MILLION) 243
TABLE 271 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 243
TABLE 272 EUROPE: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 244
TABLE 273 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 244
TABLE 274 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 275 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 245
TABLE 276 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 245
TABLE 277 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 246
TABLE 278 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 246
TABLE 279 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 247
TABLE 280 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 247
TABLE 281 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 248
TABLE 282 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 248
TABLE 283 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 248
TABLE 284 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 285 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 249
TABLE 286 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 250
TABLE 287 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 250
TABLE 288 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 251
TABLE 289 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 251
TABLE 290 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 251
TABLE 291 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 252
TABLE 292 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION,
2024–2031 (USD MILLION) 253
TABLE 293 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 253
TABLE 294 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 254
TABLE 295 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 254
TABLE 296 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 255
TABLE 297 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 255
TABLE 298 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 255
TABLE 299 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 256
TABLE 300 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 256
TABLE 301 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 257
TABLE 302 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 257
TABLE 303 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 258
TABLE 304 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 258
TABLE 305 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 258
TABLE 306 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 307 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 260
TABLE 308 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 260
TABLE 309 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 261
TABLE 310 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 261
TABLE 311 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 262
TABLE 312 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 262
TABLE 313 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 262
TABLE 314 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION,
2024–2031 (USD MILLION) 263
TABLE 315 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 264
TABLE 316 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 264
TABLE 317 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 265
TABLE 318 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 265
TABLE 319 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 265
TABLE 320 GCC COUNTRIES: PROTEIN EXPRESSION MARKET PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 266
TABLE 321 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 266
TABLE 322 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 267
TABLE 323 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 267
TABLE 324 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 268
TABLE 325 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 268
TABLE 326 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 268
TABLE 327 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 269
TABLE 328 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 269
TABLE 329 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 270
TABLE 330 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 270
TABLE 331 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 271
TABLE 332 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 271
TABLE 333 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION REGION, BY COUNTRY, 2024–2031 (USD MILLION) 271
TABLE 334 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 272
TABLE 335 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 336 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 273
TABLE 337 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 273
TABLE 338 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 274
TABLE 339 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 274
TABLE 340 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 275
TABLE 341 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 275
TABLE 342 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 275
TABLE 343 PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 276
TABLE 344 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 277
TABLE 345 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 277
TABLE 346 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 278
TABLE 347 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 278
TABLE 348 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 278
TABLE 349 GCC COUNTRIES: PROTEIN EXPRESSION MARKET E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 279
TABLE 350 PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 279
TABLE 351 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 280
TABLE 352 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 280
TABLE 353 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 281
TABLE 354 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 281
TABLE 355 MIDDLE EAST: PROTEIN EXPRESSION MARKET OTHER CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 281
TABLE 356 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 282
TABLE 357 PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 283
TABLE 358 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 283
TABLE 359 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 284
TABLE 360 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 284
TABLE 361 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 285
TABLE 362 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 285
TABLE 363 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 285
TABLE 364 PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 287
TABLE 365 PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024–2031 (USD MILLION) 288
TABLE 366 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 288
TABLE 367 EUROPE: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION,
BY COUNTRY, 2024–2031 (USD MILLION) 289
TABLE 368 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION,
BY COUNTRY, 2024–2031 (USD MILLION) 289
TABLE 369 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 290
TABLE 370 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024–2031 (USD MILLION) 290
TABLE 371 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 290
TABLE 372 PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2024–2031 (USD MILLION) 291
TABLE 373 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,
2024–2031 (USD MILLION) 292
TABLE 374 EUROPE: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,
2024–2031 (USD MILLION) 292
TABLE 375 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,
2024–2031 (USD MILLION) 293
TABLE 376 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,
2024–2031 (USD MILLION) 293
TABLE 377 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION,
2024–2031 (USD MILLION) 293
TABLE 378 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY,
2024–2031 (USD MILLION) 294
TABLE 379 PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION) 295
TABLE 380 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY,
2024–2031 (USD MILLION) 295
TABLE 381 EUROPE: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 296
TABLE 382 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 296
TABLE 383 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 297
TABLE 384 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION) 297
TABLE 385 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 297
TABLE 386 PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION,
2024–2031 (USD MILLION) 299
TABLE 387 PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024–2031 (USD MILLION) 300
TABLE 388 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 300
TABLE 389 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 301
TABLE 390 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 301
TABLE 391 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 302
TABLE 392 MIDDLE EAST: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024–2031 (USD MILLION) 302
TABLE 393 GCC COUNTRIES: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 302
TABLE 394 PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024–2031 (USD MILLION) 303
TABLE 395 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 304
TABLE 396 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 304
TABLE 397 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 305
TABLE 398 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 305
TABLE 399 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024–2031 (USD MILLION) 305
TABLE 400 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 306
TABLE 401 PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024–2031 (USD MILLION) 307
TABLE 402 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 307
TABLE 403 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 308
TABLE 404 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 308
TABLE 405 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 309
TABLE 406 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024–2031 (USD MILLION) 309
TABLE 407 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 309
TABLE 408 PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY,
2024–2031 (USD MILLION) 311
TABLE 409 PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024–2031 (USD MILLION) 312
TABLE 410 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 312
TABLE 411 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 313
TABLE 412 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 313
TABLE 413 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 314
TABLE 414 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024–2031 (USD MILLION) 314
TABLE 415 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 314
TABLE 416 PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 315
TABLE 417 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 316
TABLE 418 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 316
TABLE 419 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 317
TABLE 420 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 317
TABLE 421 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 317
TABLE 422 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 318
TABLE 423 PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY REGION,
2024–2031 (USD MILLION) 318
TABLE 424 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 319
TABLE 425 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 319
TABLE 426 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 320
TABLE 427 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 320
TABLE 428 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES,
BY REGION, 2024–2031 (USD MILLION) 320
TABLE 429 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES,
BY COUNTRY, 2024–2031 (USD MILLION) 321
TABLE 430 PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 321
TABLE 431 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 322
TABLE 432 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 322
TABLE 433 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 323
TABLE 434 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 323
TABLE 435 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 323
TABLE 436 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 324
TABLE 437 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION) 324
TABLE 438 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 325
TABLE 439 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS,
BY COUNTRY, 2024–2031 (USD MILLION) 325
TABLE 440 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 326
TABLE 441 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 326
TABLE 442 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION) 326
TABLE 443 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 327
TABLE 444 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 329
TABLE 445 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 330
TABLE 446 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 330
TABLE 447 EUROPE: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 331
TABLE 448 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 331
TABLE 449 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 332
TABLE 450 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 332
TABLE 451 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 332
TABLE 452 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 334
TABLE 453 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 334
TABLE 454 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 335
TABLE 455 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 335
TABLE 456 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 336
TABLE 457 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2024–2031 (USD MILLION) 336
TABLE 458 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 336
TABLE 459 LIST OF INDUSTRIAL ENZYMES AND APPLICATIONS 337
TABLE 460 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 338
TABLE 461 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 339
TABLE 462 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 339
TABLE 463 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 340
TABLE 464 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 340
TABLE 465 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS,
BY REGION, 2024–2031 (USD MILLION) 340
TABLE 466 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 341
TABLE 467 PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 342
TABLE 468 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 342
TABLE 469 EUROPE: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 343
TABLE 470 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 343
TABLE 471 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 344
TABLE 472 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 344
TABLE 473 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 344
TABLE 474 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 346
TABLE 475 PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 347
TABLE 476 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2024–2031 (USD MILLION) 347
TABLE 477 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 348
TABLE 478 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 348
TABLE 479 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2024–2031 (USD MILLION) 349
TABLE 480 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 349
TABLE 481 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2024–2031 (USD MILLION) 349
TABLE 482 PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 350
TABLE 483 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 351
TABLE 484 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 351
TABLE 485 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 352
TABLE 486 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 352
TABLE 487 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 352
TABLE 488 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 353
TABLE 489 PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 354
TABLE 490 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 354
TABLE 491 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 355
TABLE 492 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 355
TABLE 493 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 356
TABLE 494 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 356
TABLE 495 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 356
TABLE 496 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 357
TABLE 497 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER
END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 358
TABLE 498 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 358
TABLE 499 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 359
TABLE 500 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER
END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 359
TABLE 501 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER
END USERS, BY REGION, 2024–2031 (USD MILLION) 359
TABLE 502 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER
END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 360
TABLE 503 PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 362
TABLE 504 PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 363
TABLE 505 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2024–2031 (USD MILLION) 363
TABLE 506 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 364
TABLE 507 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 364
TABLE 508 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 365
TABLE 509 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 365
TABLE 510 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2024–2031 (USD MILLION) 365
TABLE 511 PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 366
TABLE 512 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 367
TABLE 513 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 367
TABLE 514 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 368
TABLE 515 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 368
TABLE 516 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 368
TABLE 517 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 369
TABLE 518 PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 369
TABLE 519 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER
END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 370
TABLE 520 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2024–2031 (USD MILLION) 370
TABLE 521 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 371
TABLE 522 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER
END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 371
TABLE 523 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 371
TABLE 524 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER
END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 372
TABLE 525 PROTEIN EXPRESSION MARKET, BY REGION, 2024–2031 (USD MILLION) 374
TABLE 526 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 375
TABLE 527 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 376
TABLE 528 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 376
TABLE 529 NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 377
TABLE 530 NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 377
TABLE 531 NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 378
TABLE 532 NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 378
TABLE 533 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 379
TABLE 534 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 379
TABLE 535 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 380
TABLE 536 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 380
TABLE 537 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 381
TABLE 538 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 381
TABLE 539 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 381
TABLE 540 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 382
TABLE 541 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 382
TABLE 542 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 383
TABLE 543 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 383
TABLE 544 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 384
TABLE 545 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 384
TABLE 546 US: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 385
TABLE 547 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 385
TABLE 548 US: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 386
TABLE 549 US: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 386
TABLE 550 US: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 387
TABLE 551 US: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387
TABLE 552 US: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 388
TABLE 553 US: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 388
TABLE 554 US: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 389
TABLE 555 US: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 389
TABLE 556 US: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 390
TABLE 557 US: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 390
TABLE 558 US: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 390
TABLE 559 US: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 391
TABLE 560 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION,
2024–2031 (USD MILLION) 391
TABLE 561 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY,
2024–2031 (USD MILLION) 392
TABLE 562 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392
TABLE 563 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 393
TABLE 564 US: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 393
TABLE 565 CANADA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 394
TABLE 566 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 394
TABLE 567 CANADA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 395
TABLE 568 CANADA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 395
TABLE 569 CANADA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 396
TABLE 570 CANADA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 396
TABLE 571 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 397
TABLE 572 CANADA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 397
TABLE 573 CANADA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 398
TABLE 574 CANADA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 398
TABLE 575 CANADA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 399
TABLE 576 CANADA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 399
TABLE 577 CANADA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 399
TABLE 578 CANADA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 400
TABLE 579 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 400
TABLE 580 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 401
TABLE 581 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 401
TABLE 582 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 402
TABLE 583 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 402
TABLE 584 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 403
TABLE 585 EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 403
TABLE 586 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 404
TABLE 587 EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 404
TABLE 588 EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 405
TABLE 589 EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 405
TABLE 590 EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 406
TABLE 591 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 406
TABLE 592 EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 406
TABLE 593 EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 407
TABLE 594 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 407
TABLE 595 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 408
TABLE 596 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 408
TABLE 597 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 408
TABLE 598 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 409
TABLE 599 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 409
TABLE 600 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 410
TABLE 601 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 410
TABLE 602 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 411
TABLE 603 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 411
TABLE 604 GERMANY: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 412
TABLE 605 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 412
TABLE 606 GERMANY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 413
TABLE 607 GERMANY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 413
TABLE 608 GERMANY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 414
TABLE 609 GERMANY: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 414
TABLE 610 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 415
TABLE 611 GERMANY: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 415
TABLE 612 GERMANY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 416
TABLE 613 GERMANY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 416
TABLE 614 GERMANY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 417
TABLE 615 GERMANY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 417
TABLE 616 GERMANY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 417
TABLE 617 GERMANY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 418
TABLE 618 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 418
TABLE 619 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 419
TABLE 620 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 419
TABLE 621 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 420
TABLE 622 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 420
TABLE 623 UK: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 421
TABLE 624 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 421
TABLE 625 UK: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 422
TABLE 626 UK: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 422
TABLE 627 UK: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 423
TABLE 628 UK: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423
TABLE 629 UK: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 423
TABLE 630 UK: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 424
TABLE 631 UK: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 424
TABLE 632 UK: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 425
TABLE 633 UK: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 425
TABLE 634 UK: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 425
TABLE 635 UK: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 426
TABLE 636 UK: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 426
TABLE 637 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION,
2024–2031 (USD MILLION) 426
TABLE 638 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY,
2024–2031 (USD MILLION) 427
TABLE 639 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 427
TABLE 640 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 428
TABLE 641 UK: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 428
TABLE 642 FRANCE: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 429
TABLE 643 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 429
TABLE 644 FRANCE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 430
TABLE 645 FRANCE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 430
TABLE 646 FRANCE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 431
TABLE 647 FRANCE: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 431
TABLE 648 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 431
TABLE 649 FRANCE: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 432
TABLE 650 FRANCE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 432
TABLE 651 FRANCE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 433
TABLE 652 FRANCE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 433
TABLE 653 FRANCE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 433
TABLE 654 FRANCE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 434
TABLE 655 FRANCE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 434
TABLE 656 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 434
TABLE 657 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 435
TABLE 658 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 435
TABLE 659 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 436
TABLE 660 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 436
TABLE 661 ITALY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 437
TABLE 662 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 437
TABLE 663 ITALY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 438
TABLE 664 ITALY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 438
TABLE 665 ITALY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 439
TABLE 666 ITALY: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 439
TABLE 667 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 439
TABLE 668 ITALY: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 440
TABLE 669 ITALY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 440
TABLE 670 ITALY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 441
TABLE 671 ITALY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 441
TABLE 672 ITALY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 441
TABLE 673 ITALY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 442
TABLE 674 ITALY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 442
TABLE 675 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 442
TABLE 676 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY,
2024–2031 (USD MILLION) 443
TABLE 677 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 443
TABLE 678 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 444
TABLE 679 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 444
TABLE 680 SPAIN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 445
TABLE 681 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 445
TABLE 682 SPAIN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 446
TABLE 683 SPAIN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 446
TABLE 684 SPAIN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 447
TABLE 685 SPAIN: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 447
TABLE 686 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 447
TABLE 687 SPAIN: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 448
TABLE 688 SPAIN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 448
TABLE 689 SPAIN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 449
TABLE 690 SPAIN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 449
TABLE 691 SPAIN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 449
TABLE 692 SPAIN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 450
TABLE 693 SPAIN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 450
TABLE 694 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 450
TABLE 695 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY,
2024–2031 (USD MILLION) 451
TABLE 696 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 451
TABLE 697 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 452
TABLE 698 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 452
TABLE 699 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 453
TABLE 700 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 453
TABLE 701 NETHERLANDS: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 454
TABLE 702 NETHERLANDS: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 454
TABLE 703 NETHERLANDS: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 455
TABLE 704 NETHERLANDS: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 455
TABLE 705 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 455
TABLE 706 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 456
TABLE 707 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 456
TABLE 708 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 457
TABLE 709 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 457
TABLE 710 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 457
TABLE 711 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 458
TABLE 712 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 458
TABLE 713 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 458
TABLE 714 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 459
TABLE 715 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 459
TABLE 716 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 460
TABLE 717 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 460
TABLE 718 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 461
TABLE 719 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 461
TABLE 720 REST OF EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 462
TABLE 721 REST OF EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 462
TABLE 722 REST OF EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 463
TABLE 723 REST OF EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 463
TABLE 724 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 464
TABLE 725 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 464
TABLE 726 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 465
TABLE 727 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 465
TABLE 728 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 729 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 730 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 731 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 467
TABLE 732 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 467
TABLE 733 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 468
TABLE 734 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 468
TABLE 735 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 469
TABLE 736 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 469
TABLE 737 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 471
TABLE 738 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 472
TABLE 739 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 472
TABLE 740 ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 472
TABLE 741 ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 473
TABLE 742 ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 473
TABLE 743 ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 474
TABLE 744 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 474
TABLE 745 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 475
TABLE 746 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 475
TABLE 747 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 476
TABLE 748 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 476
TABLE 749 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 476
TABLE 750 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 477
TABLE 751 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 477
TABLE 752 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 477
TABLE 753 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 478
TABLE 754 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 478
TABLE 755 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 479
TABLE 756 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 479
TABLE 757 CHINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 480
TABLE 758 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 480
TABLE 759 CHINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 481
TABLE 760 CHINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 481
TABLE 761 CHINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 482
TABLE 762 CHINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 482
TABLE 763 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 482
TABLE 764 CHINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 483
TABLE 765 CHINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 483
TABLE 766 CHINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 767 CHINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 768 CHINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 769 CHINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 485
TABLE 770 CHINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 485
TABLE 771 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 485
TABLE 772 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 486
TABLE 773 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 486
TABLE 774 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 487
TABLE 775 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 487
TABLE 776 JAPAN: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 488
TABLE 777 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 489
TABLE 778 JAPAN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 489
TABLE 779 JAPAN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 490
TABLE 780 JAPAN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 490
TABLE 781 JAPAN: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 490
TABLE 782 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 491
TABLE 783 JAPAN: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 491
TABLE 784 JAPAN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 492
TABLE 785 JAPAN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 492
TABLE 786 JAPAN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 493
TABLE 787 JAPAN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 493
TABLE 788 JAPAN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 493
TABLE 789 JAPAN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 494
TABLE 790 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 494
TABLE 791 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 494
TABLE 792 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 495
TABLE 793 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 495
TABLE 794 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 495
TABLE 795 INDIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 496
TABLE 796 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 497
TABLE 797 INDIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 497
TABLE 798 INDIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 498
TABLE 799 INDIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 498
TABLE 800 INDIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 498
TABLE 801 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 499
TABLE 802 INDIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 499
TABLE 803 INDIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 500
TABLE 804 INDIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 500
TABLE 805 INDIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 501
TABLE 806 INDIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 501
TABLE 807 INDIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 501
TABLE 808 INDIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 502
TABLE 809 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 502
TABLE 810 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY,
2024–2031 (USD MILLION) 502
TABLE 811 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 503
TABLE 812 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 503
TABLE 813 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 503
TABLE 814 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 504
TABLE 815 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 504
TABLE 816 AUSTRALIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 505
TABLE 817 AUSTRALIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 505
TABLE 818 AUSTRALIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 506
TABLE 819 AUSTRALIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 506
TABLE 820 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 506
TABLE 821 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 507
TABLE 822 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 507
TABLE 823 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 824 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 825 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 826 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 827 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 828 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 509
TABLE 829 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 510
TABLE 830 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 510
TABLE 831 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 511
TABLE 832 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 511
TABLE 833 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 512
TABLE 834 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 512
TABLE 835 SOUTH KOREA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 513
TABLE 836 SOUTH KOREA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 513
TABLE 837 SOUTH KOREA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 514
TABLE 838 SOUTH KOREA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 514
TABLE 839 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 515
TABLE 840 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 515
TABLE 841 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 516
TABLE 842 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 516
TABLE 843 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 517
TABLE 844 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 517
TABLE 845 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 517
TABLE 846 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 518
TABLE 847 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 518
TABLE 848 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 518
TABLE 849 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 519
TABLE 850 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 519
TABLE 851 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 519
TABLE 852 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 520
TABLE 853 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 521
TABLE 854 REST OF ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 521
TABLE 855 REST OF ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 522
TABLE 856 REST OF ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 522
TABLE 857 REST OF ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 523
TABLE 858 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 523
TABLE 859 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 524
TABLE 860 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 524
TABLE 861 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 525
TABLE 862 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 525
TABLE 863 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 525
TABLE 864 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 526
TABLE 865 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 526
TABLE 866 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 526
TABLE 867 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 527
TABLE 868 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 527
TABLE 869 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 528
TABLE 870 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 528
TABLE 871 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 529
TABLE 872 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 529
TABLE 873 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 530
TABLE 874 LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 530
TABLE 875 LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 531
TABLE 876 LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 531
TABLE 877 LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 532
TABLE 878 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 532
TABLE 879 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 533
TABLE 880 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 533
TABLE 881 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 534
TABLE 882 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 534
TABLE 883 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 534
TABLE 884 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 535
TABLE 885 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 535
TABLE 886 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 535
TABLE 887 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 536
TABLE 888 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 536
TABLE 889 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 537
TABLE 890 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 537
TABLE 891 BRAZIL: BRAZIL: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 538
TABLE 892 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 538
TABLE 893 BRAZIL: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 538
TABLE 894 BRAZIL: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 539
TABLE 895 BRAZIL: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 539
TABLE 896 BRAZIL: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 539
TABLE 897 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 540
TABLE 898 BRAZIL: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 540
TABLE 899 BRAZIL: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 541
TABLE 900 BRAZIL: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 541
TABLE 901 BRAZIL: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 902 BRAZIL: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 903 BRAZIL: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 904 BRAZIL: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 543
TABLE 905 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 543
TABLE 906 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 543
TABLE 907 BRAZIL: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 544
TABLE 908 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 544
TABLE 909 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 544
TABLE 910 MEXICO: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 545
TABLE 911 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 545
TABLE 912 MEXICO: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 546
TABLE 913 MEXICO: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 546
TABLE 914 MEXICO: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 547
TABLE 915 MEXICO: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 547
TABLE 916 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 547
TABLE 917 MEXICO: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 548
TABLE 918 MEXICO: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 548
TABLE 919 MEXICO: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 549
TABLE 920 MEXICO: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 549
TABLE 921 MEXICO: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 549
TABLE 922 MEXICO: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 550
TABLE 923 MEXICO: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 550
TABLE 924 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 550
TABLE 925 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 551
TABLE 926 MEXICO: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 551
TABLE 927 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 552
TABLE 928 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 552
TABLE 929 ARGENTINA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 553
TABLE 930 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 553
TABLE 931 ARGENTINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 553
TABLE 932 ARGENTINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 554
TABLE 933 ARGENTINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 554
TABLE 934 ARGENTINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 554
TABLE 935 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 555
TABLE 936 ARGENTINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 555
TABLE 937 ARGENTINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 556
TABLE 938 ARGENTINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 556
TABLE 939 ARGENTINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 557
TABLE 940 ARGENTINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 557
TABLE 941 ARGENTINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 557
TABLE 942 ARGENTINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 558
TABLE 943 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 558
TABLE 944 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 558
TABLE 945 ARGENTINA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 559
TABLE 946 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 559
TABLE 947 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 559
TABLE 948 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 560
TABLE 949 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 560
TABLE 950 REST OF LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 561
TABLE 951 REST OF LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 561
TABLE 952 REST OF LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 562
TABLE 953 REST OF LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 562
TABLE 954 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 562
TABLE 955 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 563
TABLE 956 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 563
TABLE 957 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 564
TABLE 958 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 564
TABLE 959 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 564
TABLE 960 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 961 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 962 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 565
TABLE 963 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 566
TABLE 964 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 566
TABLE 965 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY END USER, 2024–2031 (USD MILLION) 567
TABLE 966 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 567
TABLE 967 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY REGION,
2024–2031 (USD MILLION) 568
TABLE 968 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 568
TABLE 969 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 569
TABLE 970 MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 569
TABLE 971 MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 570
TABLE 972 MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 570
TABLE 973 MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 570
TABLE 974 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 571
TABLE 975 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 571
TABLE 976 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 572
TABLE 977 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 572
TABLE 978 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 573
TABLE 979 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 573
TABLE 980 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 573
TABLE 981 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 574
TABLE 982 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 574
TABLE 983 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 574
TABLE 984 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 575
TABLE 985 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 575
TABLE 986 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 575
TABLE 987 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 576
TABLE 988 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 576
TABLE 989 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 577
TABLE 990 GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 577
TABLE 991 GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 578
TABLE 992 GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 578
TABLE 993 GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 579
TABLE 994 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 579
TABLE 995 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 580
TABLE 996 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 580
TABLE 997 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 581
TABLE 998 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 581
TABLE 999 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 581
TABLE 1000 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 582
TABLE 1001 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 582
TABLE 1002 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 582
TABLE 1003 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 583
TABLE 1004 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 583
TABLE 1005 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 584
TABLE 1006 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 584
TABLE 1007 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 585
TABLE 1008 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 585
TABLE 1009 SAUDI ARABIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 586
TABLE 1010 SAUDI ARABIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 586
TABLE 1011 SAUDI ARABIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 587
TABLE 1012 SAUDI ARABIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 587
TABLE 1013 SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 587
TABLE 1014 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 588
TABLE 1015 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 588
TABLE 1016 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 589
TABLE 1017 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 589
TABLE 1018 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 589
TABLE 1019 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 590
TABLE 1020 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 590
TABLE 1021 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 590
TABLE 1022 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 591
TABLE 1023 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 591
TABLE 1024 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 592
TABLE 1025 SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 592
TABLE 1026 UAE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 593
TABLE 1027 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 593
TABLE 1028 UAE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 594
TABLE 1029 UAE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 594
TABLE 1030 UAE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 595
TABLE 1031 UAE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 595
TABLE 1032 UAE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 595
TABLE 1033 UAE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 596
TABLE 1034 UAE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 596
TABLE 1035 UAE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 597
TABLE 1036 UAE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 597
TABLE 1037 UAE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 597
TABLE 1038 UAE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 598
TABLE 1039 UAE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 598
TABLE 1040 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION,
2024–2031 (USD MILLION) 598
TABLE 1041 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY,
2024–2031 (USD MILLION) 599
TABLE 1042 UAE: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 599
TABLE 1043 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 600
TABLE 1044 UAE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 600
TABLE 1045 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 601
TABLE 1046 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 601
TABLE 1047 REST OF GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 601
TABLE 1048 REST OF GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 602
TABLE 1049 REST OF GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 602
TABLE 1050 REST OF GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 603
TABLE 1051 REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 603
TABLE 1052 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 604
TABLE 1053 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 604
TABLE 1054 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 605
TABLE 1055 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 605
TABLE 1056 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 605
TABLE 1057 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 606
TABLE 1058 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 606
TABLE 1059 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 606
TABLE 1060 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 607
TABLE 1061 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 607
TABLE 1062 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET,
BY END USER, 2024–2031 (USD MILLION) 608
TABLE 1063 REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 608
TABLE 1064 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 609
TABLE 1065 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 609
TABLE 1066 REST OF MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 610
TABLE 1067 REST OF MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 610
TABLE 1068 REST OF MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 611
TABLE 1069 REST OF MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 611
TABLE 1070 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 611
TABLE 1071 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 612
TABLE 1072 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE,
2024–2031 (USD MILLION) 612
TABLE 1073 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 613
TABLE 1074 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 613
TABLE 1075 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 613
TABLE 1076 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 614
TABLE 1077 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 614
TABLE 1078 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET,
BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 614
TABLE 1079 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET,
BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 615
TABLE 1080 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 615
TABLE 1081 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 616
TABLE 1082 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 616
TABLE 1083 AFRICA: PROTEIN EXPRESSION MARKET, BY OFFERING,
2024–2031 (USD MILLION) 617
TABLE 1084 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 617
TABLE 1085 AFRICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 618
TABLE 1086 AFRICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 618
TABLE 1087 AFRICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE,
2024–2031 (USD MILLION) 619
TABLE 1088 AFRICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE,
2024–2031 (USD MILLION) 619
TABLE 1089 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 619
TABLE 1090 AFRICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW,
2024–2031 (USD MILLION) 620
TABLE 1091 AFRICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 620
TABLE 1092 AFRICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 621
TABLE 1093 AFRICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 621
TABLE 1094 AFRICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 621
TABLE 1095 AFRICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS,
BY TYPE, 2024–2031 (USD MILLION) 622
TABLE 1096 AFRICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 622
TABLE 1097 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 622
TABLE 1098 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 623
TABLE 1099 AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 623
TABLE 1100 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER,
2024–2031 (USD MILLION) 624
TABLE 1101 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 624
TABLE 1102 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
PROTEIN EXPRESSION MARKET 626
TABLE 1103 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION 629
TABLE 1104 PROTEIN EXPRESSION MARKET: REGION FOOTPRINT 633
TABLE 1105 PROTEIN EXPRESSION MARKET: OFFERING FOOTPRINT 634
TABLE 1106 PROTEIN EXPRESSION MARKET: TYPE FOOTPRINT 635
TABLE 1107 PROTEIN EXPRESSION MARKET: APPLICATION FOOTPRINT 637
TABLE 1108 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 640
TABLE 1109 PROTEIN EXPRESSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 641
TABLE 1110 PROTEIN EXPRESSION MARKET: PRODUCT & SERVICE LAUNCHES,
JANUARY 2023–MAY 2026 644
TABLE 1111 PROTEIN EXPRESSION MARKET: DEALS, JANUARY 2023–MAY 2026 645
TABLE 1112 PROTEIN EXPRESSION MARKET: EXPANSIONS, JANUARY 2023–MAY 2026 646
TABLE 1113 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 647
TABLE 1114 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED 648
TABLE 1115 THERMO FISHER SCIENTIFIC INC.: PRODUCT & SERVICE LAUNCHES,
JANUARY 2023–MAY 2026 652
TABLE 1116 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2023–MAY 2026 653
TABLE 1117 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–MAY 2026 653
TABLE 1118 MERCK KGAA: COMPANY OVERVIEW 655
TABLE 1119 MERCK KGAA: PRODUCTS & SERVICES OFFERED 656
TABLE 1120 MERCK KGAA: DEALS, JANUARY 2023–MAY 2026 659
TABLE 1121 MERCK KGAA: EXPANSIONS, JANUARY 2023–MAY 2026 659
TABLE 1122 DANAHER CORPORATION: COMPANY OVERVIEW 662
TABLE 1123 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED 663
TABLE 1124 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 665
TABLE 1125 DANAHER CORPORATION: DEALS, JANUARY 2023–MAY 2026 666
TABLE 1126 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026 666
TABLE 1127 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 668
TABLE 1128 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED 669
TABLE 1129 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 672
TABLE 1130 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–MAY 2026 672
TABLE 1131 SARTORIUS AG: COMPANY OVERVIEW 674
TABLE 1132 SARTORIUS AG: PRODUCTS & SERVICES OFFERED 675
TABLE 1133 SARTORIUS AG: DEALS, JANUARY 2023–MAY 2026 676
TABLE 1134 SARTORIUS AG: EXPANSIONS, JANUARY 2023–MAY 2026 676
TABLE 1135 GENSCRIPT: COMPANY OVERVIEW 678
TABLE 1136 GENSCRIPT: PRODUCTS & SERVICES OFFERED 679
TABLE 1137 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–MAY 2026 680
TABLE 1138 TAKARA BIO INC.: COMPANY OVERVIEW 681
TABLE 1139 TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED 682
TABLE 1140 TAKARA BIO INC.: EXPANSIONS, JANUARY 2023–MAY 2026 684
TABLE 1141 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 685
TABLE 1142 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED 686
TABLE 1143 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 688
TABLE 1144 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–MAY 2026 688
TABLE 1145 QIAGEN: COMPANY OVERVIEW 689
TABLE 1146 QIAGEN: PRODUCTS & SERVICES OFFERED 690
TABLE 1147 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026 691
TABLE 1148 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023- APRIL 2026 691
TABLE 1149 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 692
TABLE 1150 CHARLES RIVER LABORATORIES: PRODUCTS & SERVICES OFFERED 693
TABLE 1151 CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES,
JANUARY 2023- APRIL 2026 694
TABLE 1152 CORNING INCORPORATED: COMPANY OVERVIEW 695
TABLE 1153 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED 696
TABLE 1154 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026 698
TABLE 1155 LONZA: COMPANY OVERVIEW 699
TABLE 1156 LONZA: PRODUCTS & SERVICES OFFERED 700
TABLE 1157 LONZA: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 702
TABLE 1158 LONZA: DEALS, JANUARY 2023–MAY 2026 702
TABLE 1159 FUJIFILM CORPORATION: COMPANY OVERVIEW 703
TABLE 1160 FUJIFILM CORPORATION: PRODUCTS & SERVICES OFFERED 704
TABLE 1161 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 706
TABLE 1162 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026 706
TABLE 1163 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW 707
TABLE 1164 SYNGENE INTERNATIONAL LIMITED: PRODUCTS & SERVICES OFFERED 708
TABLE 1165 SYNGENE INTERNATIONAL LIMITED: PRODUCT LAUNCHES,
JANUARY 2023–MAY 2026 708
TABLE 1166 LGC LIMITED: COMPANY OVERVIEW 709
TABLE 1167 LGC LIMITED: PRODUCTS & SERVICES OFFERED 710
TABLE 1168 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 712
TABLE 1169 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED 713
TABLE 1170 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023- APRIL 2026 714
TABLE 1171 AJINOMOTO CO., INC.: COMPANY OVERVIEW 715
TABLE 1172 AJINOMOTO CO., INC.: PRODUCTS & SERVICES OFFERED 716
TABLE 1173 AJINOMOTO CO., INC.: DEALS, JANUARY 2023- APRIL 2026 717
TABLE 1174 PROMEGA CORPORATION: COMPANY OVERVIEW 718
TABLE 1175 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW 719
TABLE 1176 RAYBIOTECH, INC.: COMPANY OVERVIEW 720
TABLE 1177 BIONEER CORPORATION: COMPANY OVERVIEW 721
TABLE 1178 ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW 722
TABLE 1179 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 723
TABLE 1180 ACCURUS BIOSCIENCES: COMPANY OVERVIEW 724
TABLE 1181 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW 725
TABLE 1182 OXFORD EXPRESSION TECHNOLOGIES LTD: COMPANY OVERVIEW 726
TABLE 1183 PROTEOGENIX INC.: COMPANY OVERVIEW 727
TABLE 1184 ABEOMICS: COMPANY OVERVIEW 728
TABLE 1185 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 737

LIST OF FIGURES

FIGURE 1 MARKET SCENARIO 72
FIGURE 2 GLOBAL PROTEIN EXPRESSION MARKET, 2024–2031 72
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET, 2023–2026 73
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PROTEIN EXPRESSION MARKET 74
FIGURE 5 HIGH-GROWTH SEGMENTS IN PROTEIN EXPRESSION MARKET, 2026–2031 75
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN THE PROTEIN EXPRESSION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 76
FIGURE 7 CONTINUOUS INNOVATION IN EXPRESSION TECHNOLOGIES TO DRIVE GROWTH IN PROTEIN EXPRESSION MARKET 77
FIGURE 8 PRODUCT SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 78
FIGURE 9 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 79
FIGURE 10 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 80
FIGURE 11 PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS 87
FIGURE 12 PROTEIN EXPRESSION PRODUCTS MARKET: VALUE CHAIN ANALYSIS 91
FIGURE 13 PROTEIN EXPRESSION SERVICES MARKET: VALUE CHAIN ANALYSIS 92
FIGURE 14 PROTEIN EXPRESSION MARKET: ECOSYSTEM ANALYSIS 93
FIGURE 15 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER 95
FIGURE 16 INDICATIVE SELLING PRICE TREND OF PROTEIN EXPRESSION SYSTEMS,
BY REGION, 2025 (USD) 96
FIGURE 17 PROTEIN EXPRESSION MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMERS’ BUSINESSES 101
FIGURE 18 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 102
FIGURE 19 TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015–2025 111
FIGURE 20 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET 114
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 126
FIGURE 22 KEY BUYING CRITERIA, BY END USER 126
FIGURE 23 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT 375
FIGURE 24 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT 471
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS, 2023–2025 (USD MILLION) 627
FIGURE 26 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 628
FIGURE 27 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 631
FIGURE 28 PROTEIN EXPRESSION MARKET: COMPANY FOOTPRINT 632
FIGURE 29 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 639
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 642
FIGURE 31 EV/EBITDA OF KEY VENDORS 642
FIGURE 32 PROTEIN EXPRESSION MARKET: BRAND/PRODUCT COMPARISON 643
FIGURE 33 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 648
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2025) 656
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 663
FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 669
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2025) 675
FIGURE 38 GENSCRIPT: COMPANY SNAPSHOT (2025) 678
FIGURE 39 TAKARA BIO INC.: COMPANY SNAPSHOT (2025) 682
FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 686
FIGURE 41 QIAGEN: COMPANY SNAPSHOT (2025) 689
FIGURE 42 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025) 693
FIGURE 43 CORNING INCORPORATED: COMPANY SNAPSHOT (2025) 696
FIGURE 44 LONZA: COMPANY SNAPSHOT (2025) 700
FIGURE 45 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024) 704
FIGURE 46 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025) 707
FIGURE 47 LGC LIMITED: COMPANY SNAPSHOT (2025) 710
FIGURE 48 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 713
FIGURE 49 AJINOMOTO CO., INC.: COMPANY SNAPSHOT (2025) 716
FIGURE 50 RESEARCH DESIGN 729
FIGURE 51 PROTEIN EXPRESSION MARKET: BREAKDOWN OF PRIMARIES 731
FIGURE 52 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025 732
FIGURE 53 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025 733
FIGURE 54 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC. (2025) 733
FIGURE 55 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 734
FIGURE 56 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 735
FIGURE 57 PROTEIN EXPRESSION MARKET CAGR PROJECTIONS: 737
FIGURE 58 DATA TRIANGULATION METHODOLOGY 738

---

---